Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • IIAR
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • IIAR
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Inhibition of Colony-Stimulating Factor-1 Receptor Enhances the Efficacy of Radiotherapy and Reduces Immune Suppression in Glioblastoma

MUAYAD F. ALMAHARIQ, THOMAS J. QUINN, PRAVIN KESARWANI, SHIVA KANT, C. RYAN MILLER and PRAKASH CHINNAIYAN
In Vivo January 2021, 35 (1) 119-129; DOI: https://doi.org/10.21873/invivo.12239
MUAYAD F. ALMAHARIQ
1Department of Radiation Oncology, Beaumont Health, Royal Oak, MI, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
THOMAS J. QUINN
1Department of Radiation Oncology, Beaumont Health, Royal Oak, MI, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PRAVIN KESARWANI
1Department of Radiation Oncology, Beaumont Health, Royal Oak, MI, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHIVA KANT
1Department of Radiation Oncology, Beaumont Health, Royal Oak, MI, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. RYAN MILLER
2Division of Neuropathology, Department of Pathology, O’Neal Comprehensive Cancer Center, Comprehensive Neuroscience Center, University of Alabama School of Medicine, Birmingham, AL, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PRAKASH CHINNAIYAN
1Department of Radiation Oncology, Beaumont Health, Royal Oak, MI, U.S.A.;
3Oakland University William Beaumont School of Medicine, Rochester, MI, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: prakash.chinnaiyan@beaumont.edu
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 35 no. 1 119-129
DOI 
https://doi.org/10.21873/invivo.12239
PubMed 
33402457

Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received September 10, 2020
  • Revision received October 17, 2020
  • Accepted October 22, 2020
  • Published online January 5, 2021.

Copyright & Usage 
Copyright© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. MUAYAD F. ALMAHARIQ1,*,
  2. THOMAS J. QUINN1,*,
  3. PRAVIN KESARWANI1,
  4. SHIVA KANT1,
  5. C. RYAN MILLER2 and
  6. PRAKASH CHINNAIYAN1,3⇑
  1. 1Department of Radiation Oncology, Beaumont Health, Royal Oak, MI, U.S.A.;
  2. 2Division of Neuropathology, Department of Pathology, O’Neal Comprehensive Cancer Center, Comprehensive Neuroscience Center, University of Alabama School of Medicine, Birmingham, AL, U.S.A.;
  3. 3Oakland University William Beaumont School of Medicine, Rochester, MI, U.S.A.
  1. Correspondence to: Prakash Chinnaiyan, Beaumont Health, 3601 West 13 Mile, Royal Oak, MI 48073, U.S.A. Tel: +1 2485512560, Fax: +1 2485510089, e-mail: prakash.chinnaiyan{at}beaumont.edu
  1. ↵* These Authors contributed equally to this study.

View Full Text
PreviousNext
Back to top

In this issue

In Vivo: 35 (1)
In Vivo
Vol. 35, Issue 1
January-February 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Inhibition of Colony-Stimulating Factor-1 Receptor Enhances the Efficacy of Radiotherapy and Reduces Immune Suppression in Glioblastoma
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Inhibition of Colony-Stimulating Factor-1 Receptor Enhances the Efficacy of Radiotherapy and Reduces Immune Suppression in Glioblastoma
MUAYAD F. ALMAHARIQ, THOMAS J. QUINN, PRAVIN KESARWANI, SHIVA KANT, C. RYAN MILLER, PRAKASH CHINNAIYAN
In Vivo Jan 2021, 35 (1) 119-129; DOI: 10.21873/invivo.12239

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Inhibition of Colony-Stimulating Factor-1 Receptor Enhances the Efficacy of Radiotherapy and Reduces Immune Suppression in Glioblastoma
MUAYAD F. ALMAHARIQ, THOMAS J. QUINN, PRAVIN KESARWANI, SHIVA KANT, C. RYAN MILLER, PRAKASH CHINNAIYAN
In Vivo Jan 2021, 35 (1) 119-129; DOI: 10.21873/invivo.12239
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Drug Screening of Potential Multiple Target Inhibitors for Estrogen Receptor-α-positive Breast Cancer
  • Combination Cancer Therapy of a Del1 Fragment and Cisplatin Enhanced Therapeutic Efficiency In Vivo
  • TBX15 rs98422, DNM3 rs1011731, RAD51B rs8017304, and rs2588809 Gene Polymorphisms and Associations With Pituitary Adenoma
Show more Experimental Studies

Similar Articles

Keywords

  • glioblastoma
  • CSF-1R
  • M2 macrophages
  • immunosuppression
In Vivo

© 2021 In Vivo

Powered by HighWire